232 related articles for article (PubMed ID: 35744926)
1. Development of a Novel Class of Pyridazinone Derivatives as Selective MAO-B Inhibitors.
Alagöz MA; Oh JM; Zenni YN; Özdemir Z; Abdelgawad MA; Naguib IA; Ghoneim MM; Gambacorta N; Nicolotti O; Kim H; Mathew B
Molecules; 2022 Jun; 27(12):. PubMed ID: 35744926
[TBL] [Abstract][Full Text] [Related]
2. Exploration of a new class of monoamine oxidase B inhibitors by assembling benzyloxy pharmacophore on halogenated chalcones.
Singh AK; Kim SM; Oh JM; Abdelgawad MA; Ghoneim MM; Rangarajan TM; Kumar S; Sudevan ST; Trisciuzzi D; Nicolotti O; Kim H; Mathew B
Chem Biol Drug Des; 2023 Aug; 102(2):271-284. PubMed ID: 37011915
[TBL] [Abstract][Full Text] [Related]
3. Design, Synthesis, and Biological Evaluation of Pyridazinones Containing the (2-Fluorophenyl) Piperazine Moiety as Selective MAO-B Inhibitors.
Çeçen M; Oh JM; Özdemir Z; Büyüktuncel SE; Uysal M; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Mathew B; Kim H
Molecules; 2020 Nov; 25(22):. PubMed ID: 33212876
[TBL] [Abstract][Full Text] [Related]
4. Potent and highly selective dual-targeting monoamine oxidase-B inhibitors: Fluorinated chalcones of morpholine versus imidazole.
Mathew B; Baek SC; Thomas Parambi DG; Lee JP; Mathew GE; Jayanthi S; Vinod D; Rapheal C; Devikrishna V; Kondarath SS; Uddin MS; Kim H
Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800309. PubMed ID: 30663112
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, molecular modelling and biological activity of some pyridazinone derivatives as selective human monoamine oxidase-B inhibitors.
Özdemir Z; Alagöz MA; Uslu H; Karakurt A; Erikci A; Ucar G; Uysal M
Pharmacol Rep; 2020 Jun; 72(3):692-704. PubMed ID: 32144745
[TBL] [Abstract][Full Text] [Related]
6. Development of Halogenated Pyrazolines as Selective Monoamine Oxidase-B Inhibitors: Deciphering via Molecular Dynamics Approach.
Nair AS; Oh JM; Koyiparambath VP; Kumar S; Sudevan ST; Soremekun O; Soliman ME; Khames A; Abdelgawad MA; Pappachen LK; Mathew B; Kim H
Molecules; 2021 May; 26(11):. PubMed ID: 34071665
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 4-substituted benzyl-2-triazole-linked-tryptamine-paeonol derivatives and evaluation of their selective inhibitions against butyrylcholinesterase and monoamine oxidase-B.
Oh JM; Kang Y; Hwang JH; Park JH; Shin WH; Mun SK; Lee JU; Yee ST; Kim H
Int J Biol Macromol; 2022 Sep; 217():910-921. PubMed ID: 35908673
[TBL] [Abstract][Full Text] [Related]
8. (Hetero-)(arylidene)arylhydrazides as Multitarget-Directed Monoamine Oxidase Inhibitors.
Palakkathondi A; Oh JM; Dev S; Rangarajan TM; Kaipakasseri S; Kavully FS; Gambacorta N; Nicolotti O; Kim H; Mathew B
ACS Comb Sci; 2020 Nov; 22(11):592-599. PubMed ID: 33047950
[TBL] [Abstract][Full Text] [Related]
9. A New Potent and Selective Monoamine Oxidase-B Inhibitor with Extended Conjugation in a Chalcone Framework: 1-[4-(Morpholin-4-yl)phenyl]-5-phenylpenta-2,4-dien-1-one.
Maliyakkal N; Eom BH; Heo JH; Abdullah Almoyad MA; Thomas Parambi DG; Gambacorta N; Nicolotti O; Beeran AA; Kim H; Mathew B
ChemMedChem; 2020 Sep; 15(17):1629-1633. PubMed ID: 32583952
[TBL] [Abstract][Full Text] [Related]
10. Design of enamides as new selective monoamine oxidase-B inhibitors.
Kavully FS; Oh JM; Dev S; Kaipakasseri S; Palakkathondi A; Vengamthodi A; Abdul Azeez RF; Tondo AR; Nicolotti O; Kim H; Bijo Mathew
J Pharm Pharmacol; 2020 Jul; 72(7):916-926. PubMed ID: 32246471
[TBL] [Abstract][Full Text] [Related]
11. The Benzopyrone Biochanin-A as a reversible, competitive, and selective monoamine oxidase B inhibitor.
Zarmouh NO; Eyunni SK; Soliman KF
BMC Complement Altern Med; 2017 Jan; 17(1):34. PubMed ID: 28069007
[TBL] [Abstract][Full Text] [Related]
12. Trimethoxy Crown Chalcones as Multifunctional Class of Monoamine Oxidase Enzyme Inhibitors.
Maliyakkal N; Baysal I; Tengli A; Ucar G; Almoyad MAA; Parambi DGT; Gambacorta N; Nicolotti O; Beeran AA; Mathew B
Comb Chem High Throughput Screen; 2022; 25(8):1314-1326. PubMed ID: 34082669
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, in vitro and in silico evaluation of new pyrrole derivatives as monoamine oxidase inhibitors.
Altintop MD; Sever B; Osmaniye D; Sağlık BN; Özdemir A
Arch Pharm (Weinheim); 2018 Jul; 351(7):e1800082. PubMed ID: 29963739
[TBL] [Abstract][Full Text] [Related]
14. Selected Class of Enamides Bearing Nitro Functionality as Dual-Acting with Highly Selective Monoamine Oxidase-B and BACE1 Inhibitors.
Venkidath A; Oh JM; Dev S; Amin E; Rasheed SP; Vengamthodi A; Gambacorta N; Khames A; Abdelgawad MA; George G; Nicolotti O; Kim H; Mathew B
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641548
[TBL] [Abstract][Full Text] [Related]
15. Identification of Indole-Based Chalcones: Discovery of a Potent, Selective, and Reversible Class of MAO-B Inhibitors.
Sasidharan R; Manju SL; Uçar G; Baysal I; Mathew B
Arch Pharm (Weinheim); 2016 Aug; 349(8):627-37. PubMed ID: 27373997
[TBL] [Abstract][Full Text] [Related]
16. Halogenated class of oximes as a new class of monoamine oxidase-B inhibitors for the treatment of Parkinson's disease: Synthesis, biochemistry, and molecular dynamics study.
Thomas Parambi DG; Oh JM; Kumar S; Sudevan ST; Hendawy OM; Abdelgawad MA; Musa A; Al-Sanea MM; Ahmad I; Patel H; Kim H; Mathew B
Comput Biol Chem; 2023 Aug; 105():107899. PubMed ID: 37315342
[TBL] [Abstract][Full Text] [Related]
17. Isatin-tethered halogen-containing acylhydrazone derivatives as monoamine oxidase inhibitor with neuroprotective effect.
Kumar S; Oh JM; Prabhakaran P; Awasti A; Kim H; Mathew B
Sci Rep; 2024 Jan; 14(1):1264. PubMed ID: 38218887
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human monoamine oxidase A and B by flavonoids isolated from two Algerian medicinal plants.
Larit F; Elokely KM; Chaurasiya ND; Benyahia S; Nael MA; León F; Abu-Darwish MS; Efferth T; Wang YH; Belouahem-Abed D; Benayache S; Tekwani BL; Cutler SJ
Phytomedicine; 2018 Feb; 40():27-36. PubMed ID: 29496172
[TBL] [Abstract][Full Text] [Related]
19. Selective Inhibition of Human Monoamine Oxidase B by Acacetin 7-Methyl Ether Isolated from
Chaurasiya ND; Zhao J; Pandey P; Doerksen RJ; Muhammad I; Tekwani BL
Molecules; 2019 Feb; 24(4):. PubMed ID: 30813423
[TBL] [Abstract][Full Text] [Related]
20. Development of methylthiosemicarbazones as new reversible monoamine oxidase-B inhibitors for the treatment of Parkinson's disease.
Mathew GE; Oh JM; Mohan K; Tengli A; Mathew B; Kim H
J Biomol Struct Dyn; 2021 Aug; 39(13):4786-4794. PubMed ID: 32588753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
